Recent Life Sciences Patent Cases: Sound The Alarm?

Law360, New York (December 6, 2012, 4:21 PM EST) -- First, there was Mayo v. Prometheus,[1] where the Supreme Court found the medical diagnostic methods at issue were not patentable subject matter. Then, the court sent Myriad[2] back to the Federal Circuit, for further consideration of whether isolated DNA sequences are patentable. It will soon hear that case again — certiorari was just granted.

The Supreme Court has also granted review in Bowman v. Monsanto[3] on whether patent exhaustion applies to self-replicating plant seed technologies. And now, a new petition is pending before the Supreme Court...
To view the full article, register now.